Potential tumor-tropic effect of genetically engineered stem cells expressing suicide enzymes to selectively target invasive cancer in animal models

Anticancer Research

Volumn 31, Issue 4, 2011, Pages 1249-1258

  Kim, Seung U ^a   Jeung, Eui Bae ^b   Kim, Yun Bae ^b   Cho, Myung Haing ^c,d   Choi, Kyung Chul ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Chungbuk National University   (South Korea)

^c Seoul National University   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

Animal models; Gene directed enzyme prodrug therapy review; Invasive tumors; Neural stem cells; Prodrugs; Suicide genes

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; BEVACIZUMAB; CARBOPLATIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; IRINOTECAN; PACLITAXEL; SUICIDE SUBSTRATE; TOPOTECAN;

BREAST CANCER; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER GENE THERAPY; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SURGERY; CELL GROWTH; ENDOMETRIUM CANCER; EPITHELIAL OVARY CANCER; GENE DIRECTED ENZYME PRODRUG THERAPY; GENETICALLY ENGINEERED STEM CELL; GLIOBLASTOMA; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; NEUROBLASTOMA; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; REVIEW; STEM CELL; TUMOR XENOGRAFT;

ANIMALS; DISEASE MODELS, ANIMAL; GENE THERAPY; GENES, TRANSGENIC, SUICIDE; GENETIC ENGINEERING; HUMANS; NEOPLASM INVASIVENESS; NEOPLASMS, EXPERIMENTAL; STEM CELLS;

EID: 79956149612     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Aboody KS, Bush RA, Garcia E, Metz MZ, Najbauer J, Justus KA, Phelps DA, Remack JS, Yoon KJ, Gillespie S, Kim SU, Glackin CA, Potter PM and Danks MK: Development of a tumor-selective approach to treat metastatic cancer. PLoS ONE 1: e23, 2006.
2. Kim SU: Genetically engineered human neural stem cells for brain repair in neurological diseases. Brain Dev 29: 193-201, 2007.
3. Moon SY, Park YB, Kim DS, Oh SK and Kim DW: Generation, culture, and differentiation of human embryonic stem cells for therapeutic applications. Mol Ther 13: 5-14, 2006. (Pubitemid 41763478)
4. Suemori H: Establishment and therapeutic use of human embryonic stem cell lines. Hum Cell 19: 65-70, 2006.
5. Chung Y, Klimanskaya I, Becker S, Marh J, Lu SJ, Johnson J, Meisner L and Lanza R: Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres. Nature 439: 216-219, 2006. (Pubitemid 43083144)
6. Tesar PJ: Derivation of germ-line-competent embryonic stem cell lines from preblastocyst mouse embryos. Proc Natl Acad Sci USA 102: 8239-8244, 2005.
7. Weiss ML and Troyer DL: Stem cells in the umbilical cord. Stem Cell Rev 2: 155-162, 2006. (Pubitemid 46137576)
8. Sanchez-Ramos J: Stem cells from umbilical cord blood. Semin Reprod Med 24: 358-369, 2006.
9. Kim SW, Han H, Chae GT, Lee SH, Bo S, Yoon JH, Lee YS, Lee KS, Park HK and Kang KS: Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model. Stem Cells 24: 1620-1626, 2006. (Pubitemid 44464680)
10. Brustle O, Spiro AC, Karram K, Choudhary K, Okabe S and McKay RD: In vitro-generated neural precursors participate in mammalian brain development. Proc Natl Acad Sci USA 94: 14809-14814, 1997.
11. Martinez-Serrano A and Bjorklund A: Immortalized neural progenitor cells for CNS gene transfer and repair. Trends Neurosci 20: 530-538, 1997. (Pubitemid 27459659)
12. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA and Gage FH: Neurogenesis in the adult human hippocampus. Nat Med 4: 1313-1317, 1998.
13. Flax JD, Aurora S, Yang C, Simonin C, Wills AM, Billinghurst LL, Jendoubi M, Sidman RL, Wolfe JH, Kim SU and Snyder EY: Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat Biotechnol 16: 1033-1039, 1998. (Pubitemid 28515895)
14. Kim SU: Human neural stem cells genetically modified for brain repair in neurological disorders. Neuropathology 24: 159-171, 2004.
15. Danks MK, Yoon KJ, Bush RA, Remack JS, Wierdl M, Tsurkan L, Kim SU, Garcia E, Metz MZ, Najbauer J, Potter PM and Aboody KS: Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma. Cancer Res 67: 22-25, 2007. (Pubitemid 46142755)
16. Dickson PV, Hamner JB, Burger RA, Garcia E, Ouma AA, Kim SU, Ng CY, Gray JT, Aboody KS, Danks MK and Davidoff AM: Intravascular administration of tumor-tropic neural progenitor cells permits targeted delivery of interferon-beta and restricts tumor growth in a murine model of disseminated neuroblastoma. J Pediatr Surg 42: 48-53, 2007. (Pubitemid 46037712)
17. Kim SK, Cargioli TG, Machluf M, Yang W, Sun Y, Al-Hashem R, Kim SU, Black PM and Carroll RS: PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model. Clin Cancer Res 11: 5965-5970, 2005. (Pubitemid 41170327)
18. Kim SK, Kim SU, Park IH, Bang JH, Aboody KS, Wang KC, Cho BK, Kim M, Menon LG, Black PM and Carroll RS: Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin Cancer Res 12: 5550-5556, 2006. (Pubitemid 44497273)
19. Srivastava D and Ivey KN: Potential of stem cell-based therapies for heart disease. Nature 441: 1097-1099, 2006. (Pubitemid 43990723)
20. Kim SU, Nakagawa E, Hatori K, Nagai A, Lee MA and Bang JH: Production of immortalized human neural crest stem cells. Methods Mol Biol 198: 55-65, 2002.
21. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, Tsukamoto AS, Gage FH and Weissman IL: Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 97: 14720-14725, 2000. (Pubitemid 32016642)
22. Hoshimaru M, Ray J, Sah DW and Gage FH: Differentiation of the immortalized adult neuronal progenitor cell line HC2S2 into neurons by regulatable suppression of the v-myc oncogene. Proc Natl Acad Sci USA 93: 1518-1523, 1996. (Pubitemid 26075156)
23. Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD, Frenkel D, Li J, Sidman RL, Walsh CA, Snyder EY and Khoury SJ: Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci USA 101: 18117-18122, 2004. (Pubitemid 40054083)
24. Cho T, Bae JH, Choi HB, Kim SS, McLarnon JG, Sun-Kim H, Kim SU and Min CK: Human neural stem cells: electrophysiological properties of voltage-gated ion channels. Neuroreport 13: 1447-1452, 2002.
25. Ryu JK, Choi HB, Hatori K, Heisel RL, Pelech SL, McLarnon JG and Kim SU: Adenosine triphosphate induces proliferation of human neural stem cells: Role of calcium and p70 ribosomal protein S6 kinase. J Neurosci Res 72: 352-362, 2003. (Pubitemid 36504704)
26. Schepelmann S, Ogilvie LM, Hedley D, Friedlos F, Martin J, Scanlon I, Chen P, Marais R and Springer CJ: Suicide gene therapy of human colon carcinoma xenografts using an armed oncolytic adenovirus expressing carboxypeptidase G2. Cancer Res 67: 4949-4955, 2007. (Pubitemid 46910203)
27. Schepelmann S and Springer CJ: Viral vectors for gene-directed enzyme prodrug therapy. Curr Gene Ther 6: 647-670, 2006. (Pubitemid 44890548)
28. Benedetti S, Pirola B, Polio B, Magrassi L, Bruzzone MG, Rigamonti D, Galli R, Selleri S, Di Meco F, De Fraja C, Vescovi A, Cattaneo E and Finocchiaro G: Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med 6: 447-450, 2000. (Pubitemid 30208163)
29. Hiraoka K, Kimura T, Logg CR, Tai CK, Haga K, Lawson GW and Kasahara N: Therapeutic efficacy of replication-competent retrovirus vector-mediated suicide gene therapy in a multifocal colorectal cancer metastasis model. Cancer Res 67: 5345-5353, 2007. (Pubitemid 46997274)
30. Pastorakova A, Hlubinova K, Jakubikova J and Altaner C: Combine cancer gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and Herpes simplex thymidine kinase suicide gene. Neoplasma 53: 353-362, 2006. (Pubitemid 44689848)
31. Goblirsch M, Zwolak P, Ramnaraine ML, Pan W, Lynch C, Alaei P and Clohisy DR: Novel cytosine deaminase fusion gene enhances the effect of radiation on breast cancer in bone by reducing tumor burden, osteolysis, and skeletal fracture. Clin Cancer Res 12: 3168-3176, 2006. (Pubitemid 43837366)
32. Ou-Yang F, Lan KL, Chen CT, Liu JC, Weng CL, Chou CK, Xie X, Hung JY, Wei Y, Hortobagyi GN and Hung MC: Endostatin-cytosine deaminase fusion protein suppresses tumor growth by targeting neovascular endothelial cells. Cancer Res 66: 378-384, 2006. (Pubitemid 43166045)
33. Chu K, Kim M, Jeong SW, Kim SU and Yoon BW: Human neural stem cells can migrate, differentiate, and integrate after intravenous transplantation in adult rats with transient forebrain ischemia. Neurosci Lett 343: 129-133, 2003. (Pubitemid 36577532)
34. Chu K, Kim M, Park KI, Jeong SW, Park HK, Jung KH, Lee ST, Kang L, Lee K, Park DK, Kim SU and Roh JK: Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia. Brain Res 1016: 145-153, 2004. (Pubitemid 38887697)
35. Jeong SW, Chu K, Jung KH, Kim SU, Kim M and Roh JK: Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage. Stroke 34: 2258-2263, 2003. (Pubitemid 37099846)
36. Lee ST, Chu K, Park JE, Lee K, Kang L, Kim SU and Kim M: Intravenous administration of human neural stem cells induces functional recovery in Huntington's disease rat model. Neurosci Res 52: 243-249, 2005. (Pubitemid 40775763)
37. Ryu JK, Kim J, Cho SJ, Hatori K, Nagai A, Choi HB, Lee MC, McLarnon JG and Kim SU: Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease. Neurobiol Dis 16: 68-77, 2004. (Pubitemid 38569797)
38. Kim SU, Park IH, Kim TH, Kim KS, Choi HB, Hong SH, Bang JH, Lee MA, Joo IS, Lee CS and Kim YS: Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease. Neuropathology 26: 129-140, 2006.
39. Meng XL, Shen JS, Ohashi T, Maeda H, Kim SU and Eto Y: Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse. J Neurosci Res 74: 266-277, 2003. (Pubitemid 37193713)
40. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, Small JE, Herrlinger U, Ourednik V, Black PM, Breakefield XO and Snyder EY: Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 97: 12846-12851, 2000.
41. Brown AB, Yang W, Schmidt NO, Carroll R, Leishear KK, Rainov NG, Black PM, Breakefield XO and Aboody KS: Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Hum Gene Ther 14: 1777-1785, 2003. (Pubitemid 38010667)
42. Bello L, Lucini V, Carrabba G, Giussani C, Machluf M, Pluderi M, Nikas D, Zhang J, Tomei G, Villani RM, Carroll RS, Bikfalvi A and Black PM: Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2. Cancer Res 61: 8730-8736, 2001. (Pubitemid 34013884)
43. Yip S, Aboody KS, Burns M, Imitola J, Boockvar JA, Allport J, Park KI, Teng YD, Lachyankar M, Mcintosh T, O'Rourke DM, Khoury S, Weissleder R, Black PM, Weiss W and Snyder EY: Neural stem cell biology may be well suited for improving brain tumor therapies. Cancer J 9: 189-204, 2003.
44. Aboody KS, Najbauer J, Schmidt NO, Yang W, Wu JK, Zhuge Y, Przylecki W, Carroll R, Black PM and Perides G: Targeting of melanoma brain metastases using engineered neural stem/ progenitor cells. Neuro Oncol 8: 119-126, 2006. (Pubitemid 46542656)
45. Park KI, Ourednik J, Ourednik V, Taylor RM, Aboody KS, Auguste KI, Lachyankar MB, Redmond DE and Snyder EY: Global gene and cell replacement strategies via stem cells. Gene Ther 9: 613-624, 2002. (Pubitemid 34575317)
46. Muller FJ, Snyder EY and Loring JF: Gene therapy: can neural stem cells deliver? Nat Rev Neurosci 7: 75-84, 2006.
47. Ehtesham M, Yuan X, Kabos P, Chung NH, Liu G, Akasaki Y, Black KL and Yu JS: Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia 6: 287-293, 2004. (Pubitemid 38657085)
48. Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S, Passaniti A, Menon J, Walling J, Bailey R, Rosenblum M, Mikkelsen T and Fine HA: Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9: 287-300, 2006.
49. Sun L, Lee J and Fine HA: Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury. J Clin Invest 113: 1364-1374, 2004. (Pubitemid 39069935)
50. Schmidt NO, Przylecki W, Yang W, Ziu M, Teng Y, Kim SU, Black PM, Aboody KS and Carroll RS: Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia 7: 623-629, 2005. (Pubitemid 40967763)
51. Beppu K, Jaboine J, Merchant MS, Mackall CL and Thiele CJ: Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression. J Natl Cancer Inst 96: 46-55, 2004. (Pubitemid 38180959)
52. Geminder H, Sagi-Assif O, Goldberg L, Meshel T, Rechavi G, Witz IP and Ben-Baruch A: A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J Immunol 167: 4747-4757, 2001. (Pubitemid 32954357)
53. Kucia M, Reca R, Miekus K, Wanzeck J, Wojakowski W, Janowska-Wieczorek A, Ratajczak J and Ratajczak MZ: Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23: 879-894, 2005. (Pubitemid 41170944)
54. Ziu M, Schmidt NO, Cargioli TG, Aboody KS, Black PM and Carroll RS: Glioma-produced extracellular matrix influences brain tumor tropism of human neural stem cells. J Neurooncol 79: 125-133, 2006. (Pubitemid 44349939)
55. Canadia Cancer Society: Canadian Cancer Statistics 2007, pp. 1-116: 2007.
56. Auersperg N, Edelson MI, Mok SC, Johnson SW and Hamilton TC: The biology of ovarian cancer. Semin Oncol 25: 281-304, 1998. (Pubitemid 28272603)
57. Auersperg N, Wong AS, Choi KC, Kang SK and Leung PC: Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22: 255-288, 2001. (Pubitemid 32458162)
58. Holschneider CH and Berek JS: Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol 19: 3-10, 2000. (Pubitemid 30439309)
59. Bast RC Jr., Urban N, Shridhar V, Smith D, Zhang Z, Skates S, Lu K, Liu J, Fishman D and Mills G: Early detection of ovarian cancer: promise and reality. Cancer Treat Res 107: 61-97, 2002.
60. Luo LY, Katsaros D, Scorilas A, Fracchioli S, Bellino R, van Gramberen M, de Bruijn H, Henrik A, Stenman UH, Massobrio M, van der Zee AG, Vergote I and Diamandis EP: The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis. Cancer Res 63: 807-811, 2003. (Pubitemid 36231980)
61. Auersperg N: Specific keynote: experimental models of epithelial ovarian carcinogenesis. Gynecol Oncol 88: S47-51; discussion S52-45, 2003.
62. Urban N: Specific keynote: ovarian cancer risk assessment and the potential for early detection. Gynecol Oncol 88: S75-79; discussion S80-73, 2003.
63. Markman M: New, expanded, and modified use of approved antineoplastic agents in ovarian cancer. Oncologist 12: 186-190, 2007.
64. Bodurka DC, Levenback C, Wolf JK, Gano J, Wharton .JT, Kavanagh JJ and Gershenson DM: Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer. J Clin Oncol 21: 291-297, 2003. (Pubitemid 46606158)
65. Guichard SM and Danks MK: Topoisomerase enzymes as drug targets. Curr Opin Oncol 11: 482-489, 1999.
66. Morrison BH, Tang Z, Jacobs BS, Bauer JA and Lindner DJ: Apo2L/TRAIL induction and nuclear translocation of inositol hexakisphosphate kinase 2 during IFN-beta-induced apoptosis in ovarian carcinoma. Biochem J 385: 595-603, 2005. (Pubitemid 40165094)
67. Kim KY, Kim SU, Leung PC, Jeung EB and Choi KC: Influence of the prodrugs 5-fluorocytosine and CPT-11 on ovarian cancer cells using genetically engineered stem cells: tumor-tropic potential and inhibition of ovarian cancer cell growth. Cancer Sci 101: 955-962,
68. Engel JB, Keller G, Schally AV, Nagy A, Chism DD and Halmos G: Effective treatment of experimental human endometrial cancers with targeted cytotoxic luteinizing hormone-releasing hormone analogues AN-152 and AN-207. Fertil Steril 83(Suppl 1): 1125-1133, 2005. (Pubitemid 40543496)
69. Prat J, Gallardo A, Cuatrecasas M and Catasus L: Endometrial carcinoma: pathology and genetics. Pathology 39: 72-87, 2007.
70. Hecht JL and Mutter GL: Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol 24: 4783-4791, 2006. (Pubitemid 46630943)
71. Carey MS, Gawlik C, Fung-Kee-Fung M, Chambers A and Oliver T: Systematic review of systemic therapy for advanced or recurrent endometrial cancer. Gynecol Oncol 101: 158-167, 2006.
72. Pectasides D, Pectasides E and Economopoulos T: Systemic therapy in metastatic or recurrent endometrial cancer. Cancer Treat Rev 33: 177-190, 2007. (Pubitemid 46343104)
73. Hiramatsu HP, Kikuchi Y, Seto H and Nagata I: In vitro sensitivity of human endometrial cancer cell lines to paclitaxel or irinotecan (CPT-11) in combination with other aniticancer drugs. Anticancer Drugs 11: 573-578, 2000.
74. Serakinci N, Guldberg P, Burns JS, Abdallah B, Schrodder H, Jensen T and Kassem M: Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 23: 5095-5098, 2004.
75. Pastorakova A, Hlubinova K and Altaner C: Treatment of human tumor cells by combine gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and bacterial cytosine deaminase suicide gene. Neoplasma 53: 478-484, 2006. (Pubitemid 46133508)
76. Garcia-Sanchez F, Pizzorno G, Fu SQ, Nanakorn T, Krause DS, Liang J, Adams E, Leffert JJ, Yin LH, Cooperberg MR, Hanania E, Wang WL, Won JH, Peng XY, Cote R, Brown R, Burtness B, Giles R, Crystal R and Deisseroth AB: Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation. Blood 92: 672-682, 1998.
77. Sekido Y, Fong KM and Minna JD: Molecular genetics of lung cancer. Annu Rev Med 54: 73-87, 2003.
78. Doll SR: Smoking and lung cancer. Am J Respir Crit Care Med 162: 4-6, 2000.
79. van Zandwijk N, Mooi WJ and Rodenhuis S: Prognostic factors in NSCLC. Recent experiences. Lung Cancer 12(Suppl 1): S27-33, 1995.
80. Schiller JH: Current standards of care in small-cell and non-small-cell lung cancer. Oncology 61(Suppl 1): 3-13, 2001.
81. Travis WD: Pathology of lung cancer. Clin Chest Med 23: 65-81, viii, 2002.
82. Zochbauer-Muller S, Fong KM, Maitra A, Lam S, Geradts J, Ashfaq R, Virmani AK, Milchgrub S, Gazdar AF and Minna JD: 5′ CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Cancer Res 61: 3581-3585, 2001.
83. Travis WD, Travis LB and Devesa SS: Lung cancer. Cancer 75: 191-202, 1995.
84. Worden FP and Kalemkerian GP: Therapeutic advances in small cell lung cancer. Expert Opin Investig Drugs 9: 565-579, 2000. (Pubitemid 30119694)
85. Meuwissen R and Berns A: Mouse models for human lung cancer. Genes Dev 19: 643-664, 2005. (Pubitemid 40395076)
86. Fisher GH, Wellen SL, Klimstra D, Lenczowski JM, Tichelaar JW, Lizak MJ, Whitsett JA, Koretsky A and Varmus HE: Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev 15: 3249-3262, 2001. (Pubitemid 34008191)
87. Pellegata NS, Antoniono RJ, Redpath JL and Stanbridge EJ: DNA damage and p53-mediated cell cycle arrest: a reevaluation. Proc Natl Acad Sci USA 93: 15209-15214, 1996. (Pubitemid 27009578)
88. Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, Tuveson DA and Jacks T: Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410: 1111-1116, 2001. (Pubitemid 32391044)
89. Jin H, Kim TH, Hwang SK, Chang SH, Kim HW, Anderson HK, Lee HW, Lee KH, Colburn NH, Yang HS, Cho MH and Cho CS: Aerosol delivery of urocanic acid-modified chitosan/ programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice. Mol Cancer Ther 5: 1041-1049, 2006. (Pubitemid 43724605)
90. Hwang SK, Jin H, Kwon JT, Chang SH, Kim TH, Cho CS, Lee KH, Young MR, Colburn NH, Beck GR Jr., Yang HS and Cho MH: Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice. Gene Ther 14: 1353-1361, 2007.
91. Kim HW, Park IK, Cho CS, Lee KH, Beck GR Jr., Colburn NH and Cho MH: Aerosol delivery of glucosylated polyethylenimine/phosphatase and tensin homologue deleted on chromosome 10 complex suppresses Akt downstream pathways in the lung of K-ras null mice. Cancer Res 64: 7971-7976, 2004. (Pubitemid 39446931)
92. Kim JH, Lee HJ, Kim GS, Choi DH, Lee SS, Kang JK, Chae C, Paik NW and Cho MH: Inhibitory effects of 7-hydroxy-3-methoxy-cadalene on 4- (methylinitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in A/J mice. Cancer Lett 213: 139-145, 2004. (Pubitemid 39140971)
93. Tehrani AM, Hwang SK, Kim TH, Cho CS, Hua J, Nah WS, Kwon JT, Kim JS, Chang SH, Yu KN, Park SJ, Bhandari DR, Lee KH, An GH, Beck GR Jr. and Cho MH: Aerosol delivery of Akt controls protein translation in the lungs of dual luciferase reporter mice. Gene Ther 14: 451-458, 2007.
94. Flesken-Nikitin A, Choi KC, Eng JP, Shmidt EN and Nikitin AY: Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. Cancer Res 63: 3459-3463, 2003. (Pubitemid 36793020)
95. Orsulic S, Li Y, Soslow RA, Vitale-Cross LA, Gutkind JS and Varmus HE: Induction of ovarian cancer by defined multiple genetic changes in a mouse model system. Cancer Cell 1: 53-62, 2002. (Pubitemid 41039176)
96. Xing D and Orsulic S: A mouse model for the molecular characterization of brca1-associated ovarian carcinoma. Cancer Res 66: 8949-8953, 2006. (Pubitemid 44521109)
97. Connolly DC, Bao R, Nikitin AY, Stephens KC, Poole TW, Hua X, Harris SS, Vanderhyden BC and Hamilton TC: Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res 63: 1389-1397, 2003. (Pubitemid 36348722)
98. Vanderhyden BC, Shaw TJ and Ethier JF: Animal models of ovarian cancer. Reprod Biol Endocrinol 1: 67, 2003.
99. Gomillion CT and Burg KJ: Stem cells and adipose tissue engineering. Biomaterials 27: 6052-6063, 2006. (Pubitemid 44414978)
100. Prusa AR and Hengstschlager M: Amniotic fluid cells and human stem cell research: a new connection. Med Sci Monit 8: RA253-257, 2002.